期刊文献+

ADAMTS4在心肌梗死大鼠心脏中的表达 被引量:1

Expression of ADAMTS4 in the heart of myocardial infarction rat
原文传递
导出
摘要 目的检测ADAMTS4、Versican、Aggrecan在心肌梗死大鼠心脏中的表达。方法选择雄性Wistar大鼠构建心梗模型,随机分配15只人心梗组,5只入假手术组。手术后3d处死大鼠,取左心室制作冰冻切片,再采用免疫组织化学法检测ADAMTS4、Versican及Aggrecan蛋白表达。结果ADAMTS4在梗死边缘区域心肌细胞中有表达;在梗死周围区域毛细血管内皮细胞中ADAMTS4有弱表达,Versican呈强表达;Aggrecan在心梗组及假手术组的心肌组织及血管内膜均未见表达。结论ADAMTS4参与心梗后的炎症反应,且心梗后的血管中存在着ADAMTS4对Versican的降解;Aggrecan则未参与心梗的病理生理过程。 Objective To detect the expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4), Versican, and Aggrecan in hearts of myocardial infarction rats. Methods Male Wistar rats were chosen to make myocardial infarction model. Fifteen rats were randomly assigned into the myocardial infarction group and five rats into the sham-operation group. Rats were killed 3 d after surgery and the left ventricles were taken to produce frozen section. ADAMTS4, Versican, and Aggrecan protein expressions were detected by immunohistochemistry method. Results ADAMTS4 expressed in myocardial cells at marginal zone of the infarcted area. ADAMTS4 expressed weakly while Versican expressed strongly in capillary endothelial cells of marginal zone of the infarcted area. Aggrecan showed no expression in the cardiac tissue and vascular endothelium of both myocardial infarction group and sham-operation group. Conclusions ADAMTS4 is involved in the inflammation after myocardial infarction. Degradation of ADAMTS4 to Versican exists in the vessels after myocardial infarction. Aggrecan is not involved in the pathophysiological process of myocardial infarction.
出处 《国际生物医学工程杂志》 CAS 2015年第5期286-289,I0007,共5页 International Journal of Biomedical Engineering
基金 山东省潍坊市卫生局科研基金项目(2013025)
关键词 ADAMTS4 VERSICAN AGGRECAN 心肌梗死 免疫组化 ADAMTS4 Versican Aggrecan Myocardial infarction Immunohistochemistry
  • 相关文献

参考文献28

  • 1王力,朱智明.可注射水凝胶在心肌梗死治疗中的研究进展[J].国际生物医学工程杂志,2013,36(1):56-60. 被引量:1
  • 2Inoue K, Kusachi S, Niiya K, et al. Sequential changes in thedistribution of type I and III collagens in the infarct zone:immunohistochemical study of experimental myocardial infarction inthe rat[J]. Coron Artery Dis, 1995, 6(2): 153-158.
  • 3Wollert KC, Studer R, Doerfer K, et al. Differential effects of kininson cardiomyocyte hypertrophy and interstitial collagen matrix in thesurviving myocardium after myocardial infarction in the rat [J].Circulation, 1997,95(7): 1910-1917.
  • 4Romanic AM, Buras-Kurtis CL, Gout B, et al Matrix raetalloproteinaseexpression in cardiac myocytes following myocardial infarction inthe rabbit[J]. Life Sci, 2001, 68(7): 799-814.
  • 5Peterson JT, Li Hua, Dillon L, et al. Evolution of matrix metallopro-tease and tissue inhibitor expression during heart failure progressionin the infarcted rat[J]. Cardiovasc Res, 2000, 46(2): 307-315.
  • 6Cleutjens JP, Kandala JC, Guarda E, et al. Regulation of collagendegradation in the rat myocardium after infarction[J]. J Mol CellCardiol, 1995, 27(6): 1281-1292.
  • 7Carlyle WC, Jacobson AW, Judd DL, et al. Delayed reperfusion altersmatrix metalloproteinase activity and fibronectin mRNA expressionin the infarct zone of the ligated rat heart [J]. J Mol Cell Cardiol,1997,29(9): 2451-2463.
  • 8Romanic AM, Harrison SM, Bao Wei-ke, et al. Myocardial protectionfrom ischemia/reperfusion injury by targeted deletion of matrixmetalloproteinase-9[J]. Cardiovasc Res, 2002,54(3): 549-558.
  • 9Iwanaga Y,Aoyama T, Kihara Y, et al. Excessive activation of matrixmetalloproteinases coincides with left ventricular remodeling duringtransition from hypertrophy to heart failure in hypertensive rats[J]. JAm Coll Cardiol, 2002, 39(8): 1384-1391.
  • 10Jones GC, Riley GP. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover andarthritis[J]. Arthritis Res Ther, 2005,7(4): 160-169.

二级参考文献37

  • 1常广涛,俞麟,丁建东.用于药物释放和组织修复的可注射性水凝胶[J].中国医疗器械信息,2006,12(3):4-8. 被引量:1
  • 2周康,周新民.组织工程心脏瓣膜及干细胞应用前景[J].国际生物医学工程杂志,2006,29(2):110-113. 被引量:6
  • 3Sun Yao, Weber KT. Infarct scar: a dynamic tissue[J]. Cardiovasc Res, 2000,46(2): 250-256.
  • 4Cushing MC, Anseth KS. Materials science. Hydrogel cell cultures[J]. Science, 2007, 316(5828): 1133-1134.
  • 5Wu De-qun, Wang Tao, Lu Bo, et al. Fabrication of supramolecular hydrogels for drug delivery and stem cell encapsulation[J]. Langmuir, 2008,24(18): 10306-10312.
  • 6Ye Zhao-yang, Zhou Yan, Cai Hai-bo, et al. Myocardial regeneration: Roles of stem cells and hydrogels[J]. Adv Drug Deliv Rev, 2011, 63 (8): 688-697.
  • 7Nguyen MK, Lee DS. Injectable biodegradable hydrogels[J]. Macromol Biosci, 2010, 10(6): 563-579.
  • 8Yu Lin, Ding Jian-dong. Injectable hydrogels as unique biomedical materials[J]. Chem Soc Rev, 2008, 37(8): 1473-1481.
  • 9Venugopal JR, Prahhakaran MP, Mukherjee S, et al. Biomaterial strategies for alleviation of myocardial infarction[J]. J R Soc Inter?face, 2012, 9(66): 1-19.
  • 10Cho SW, Kim IK, Bhang SH, et al. Comhined therapy with human cord blood cell transplantation and basic fibroblast growth factor delivery for treatment of myocardial infarction[J]. Eur J Heart Fail, 2007,9(10): 974-985.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部